RSV感染率太低,吉利德砍掉2项试验?

生物制品圈
Jun 27, 2025

吉利德科学公司最近估计得默默在心里吐槽:“这届病毒不行啊!” 公司寄予厚望的抗病毒药物 obeldesivir,两项正在进行的中期试验被迫终止。原因堪称魔幻 —— 上一季节呼吸道合胞病毒(RSV)感染率低到离谱!就好比你准备了一场盛大的魔术表演,结果观众席空荡荡,魔术再精彩也没了施展空间,这两项针对 obeldesivir 的试验,也因病毒 “观众” 太少而黯然收场。此前,吉利德分别在成人和儿童...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10